MDGL - Company ID 0001157601
The table below shows MADRIGAL PHARMACEUTICALS, INC.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $198.69M | $100.02M | $99.92M | $331.55M | $36.27M | $54.00M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $134.48M | $53.82M | - | - | - | - |
| Inventory | $74.84M | $34.07M | - | - | - | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $1.25B |
| $1.03B |
| $637.28M |
| $361.37M |
| $271.68M |
| $285.16M |
| Property, plant & equipment | $1.50M | $2.19M | $1.55M | $601.00K | $851.00K | $1.05M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $1.26B | $1.04B | $640.55M | $362.57M | $273.33M | $287.00M |
| Accounts payable | $48.88M | $43.60M | $28.04M | $23.83M | $21.38M | $1.02M |
| Total current liabilities | $310.29M | $169.28M | $118.55M | $115.89M | $76.84M | $46.56M |
| Long-term debt | $339.88M | $117.57M | $115.48M | $49.29M | - | - |
| Total liabilities | $656.90M | $287.86M | $235.21M | $165.18M | $77.22M | $47.02M |
| Retained earnings | -$2.09B | -$1.80B | -$1.34B | -$962.66M | -$667.31M | -$425.46M |
| Total equity | $602.69M | $754.38M | $405.33M | $197.39M | $196.11M | $239.97M |